Anavex Life Sciences Corp. (AVXL)
4.11
+0.03
(+0.74%)
USD |
NASDAQ |
Dec 11, 16:00
4.105
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 21.36M |
| ADMA Biologics, Inc. | -14.37M |
| Aldeyra Therapeutics, Inc. | 25.00M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| CorMedix, Inc. | -291.32M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.604M |
| Cash from Financing (Quarterly) | 10.02M |
| Free Cash Flow | -39.04M |
| Free Cash Flow Per Share (Quarterly) | -0.1002 |
| Free Cash Flow to Equity (Quarterly) | -8.604M |
| Free Cash Flow to Firm (Quarterly) | -8.604M |
| Free Cash Flow Yield | -11.14% |